yingweiwo

Antiviral agent 23

Cat No.:V34994 Purity: ≥98%
antiviral compound 23 (compound 11b) is an antiviral compound against enterovirus 71 (EV71) with EC50 of 94 nM.
Antiviral agent 23
Antiviral agent 23 Chemical Structure CAS No.: 35940-03-5
Product category: Enterovirus
This product is for research use only, not for human use. We do not sell to patients.
Size Price
500mg
1g
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Product Description
antiviral compound 23 (compound 11b) is an antiviral compound against enterovirus 71 (EV71) with EC50 of 94 nM. antiviral compound 23 effectively inhibits the activity of METTL3/METTL14. antiviral compound 23 may be utilized in infection studies.
Antiviral agent 23 (CAS#: 35940-03-5) is a small-molecule antiviral agent with the molecular formula C18H21N5O4 and a molecular weight of 371.39 g/mol. It is specifically designed to target enterovirus 71 (EV71), exhibiting a potent EC50 value of 94 nM. Beyond its direct antiviral effect, the compound has been identified as an effective suppressor of the METTL3/METTL14 methyltransferase complex. This dual activity suggests it may interfere with both viral replication and the host's epitranscriptomic regulation. The compound's ability to inhibit EV71 and modulate cellular methylation pathways makes it a valuable tool for studying viral pathogenesis and host-virus interactions.
Biological Activity I Assay Protocols (From Reference)
Targets
The compound's primary biological target is enterovirus 71 (EV71). It also effectively suppresses the activity of the METTL3/METTL14 complex, which is a key regulator of N6-methyladenosine (m6A) RNA methylation. By inhibiting this complex, the compound can potentially alter the stability, splicing, and translation of both host and viral RNAs. The dual targeting of a viral pathogen and a host epigenetic regulator represents a unique mechanism of action. The compound's high potency against EV71 (EC50 = 94 nM) suggests that its primary antiviral effect may be through a direct interaction with a viral component or a host factor critical for the viral life cycle.
ln Vitro
In HeLa cells, antiviral agent 23 (0-100 μM) suppresses the replication of CVA21 and EV68, with EC50 values of 36.4 and 8.9 μM, respectively[1]. METTL3/METTL14's enzymatic activity is inhibited by antiviral drug 23 (100 μM) by 74.45%[1]. Antiviral agent 23 (0-100 μM) exhibits antiviral activity against EV71 and, with an EC50 value of 94 nM, inhibits the strain BrCr's reproduction in RD cells[1].
In vitro, the compound demonstrates potent antiviral activity against enterovirus 71, with an EC50 value of 94 nM. Its cytotoxicity has been evaluated in several cell lines. In human HeLa cells, the compound showed a CC50 value greater than 100 μM. In mouse B16 and human G361 cells, the IC50 values were greater than 166.7 μM. However, it exhibited more significant antiproliferative activity against human CCRF-CEM cells, with an IC50 value of 19.1 μM. These data suggest that the compound is relatively well-tolerated in many cell types but may have antiproliferative effects in specific cell lines.
ln Vivo
Information regarding the in vivo activity of this compound in animal models is not currently available. Its biological activity has been characterized primarily through in vitro assays. The lack of in vivo data means that its pharmacokinetic properties, bioavailability, and efficacy in a living organism are unknown. Further studies are required to determine whether the promising in vitro antiviral activity translates into therapeutic benefit in an animal model. The compound's dual mechanism of action, targeting both viral replication and host methylation, warrants investigation in appropriate in vivo models of enterovirus infection.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for this compound has not been explicitly described in available literature. Given that it inhibits the METTL3/METTL14 complex, a potential biochemical assay could involve measuring the methyltransferase activity of the purified complex in the presence of the compound. This would be performed using a radioactive or fluorescent methyl donor (e.g., S-adenosylmethionine) and a synthetic RNA substrate. The inhibitory effect could be quantified by measuring the reduction in methyl group transfer. However, such a detailed biochemical characterization has not been reported, and the primary activity data is derived from cell-based assays.
Cell Assay
The in vitro cellular assay for this compound typically involves infecting susceptible cell lines, such as rhabdomyosarcoma (RD) cells or HeLa cells, with enterovirus 71. The compound is added at various concentrations, and after a suitable incubation period (e.g., 48-72 hours), the extent of viral replication is measured. This is often done by determining the viral titer using a plaque assay or by measuring the expression of viral proteins using immunofluorescence or western blotting. The compound's effect on METTL3/METTL14 activity in cells can be assessed by measuring global m6A levels in cellular RNA using a dot blot assay or by using a specific m6A antibody for immunoprecipitation followed by sequencing.
Animal Protocol
The in vivo animal experiment workflow for this compound has not been established. If an animal study were to be designed, a common approach would be to use a mouse model of enterovirus 71 infection. This could involve infecting neonatal mice with a mouse-adapted strain of EV71 via an intracranial or intraperitoneal route. The compound would then be administered at various doses and routes (e.g., oral, intraperitoneal) to evaluate its protective efficacy. The primary endpoints would include survival rate, clinical symptom score, and viral load in target tissues (e.g., brain, muscle). Histopathological analysis of tissues would also be conducted to assess tissue damage and inflammation.
References

[1]. Rational design of novel nucleoside analogues reveals potent antiviral agents for EV71. Eur J Med Chem. 2022 Nov 24;246:114942.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C18H21N5O4
Molecular Weight
371.390443563461
Exact Mass
371.159
CAS #
35940-03-5
PubChem CID
10339188
Appearance
Typically exists as solid at room temperature
LogP
1.5
tPSA
126
Hydrogen Bond Donor Count
4
Hydrogen Bond Acceptor Count
8
Rotatable Bond Count
5
Heavy Atom Count
27
Complexity
500
Defined Atom Stereocenter Count
4
SMILES
CC1=CC(=CC=C1)CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O
InChi Key
WBJVJFOITZTVRG-SCFUHWHPSA-N
InChi Code
InChI=1S/C18H21N5O4/c1-10-3-2-4-11(5-10)6-19-16-13-17(21-8-20-16)23(9-22-13)18-15(26)14(25)12(7-24)27-18/h2-5,8-9,12,14-15,18,24-26H,6-7H2,1H3,(H,19,20,21)/t12-,14-,15-,18-/m1/s1
Chemical Name
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(3-methylphenyl)methylamino]purin-9-yl]oxolane-3,4-diol
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6926 mL 13.4629 mL 26.9259 mL
5 mM 0.5385 mL 2.6926 mL 5.3852 mL
10 mM 0.2693 mL 1.3463 mL 2.6926 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us